EGFR and neoplasm: In addition, significant detectable levels of Urokinase Plasminogen Activator Receptor (UPAR) and Epidermal Growth Factor Receptor (EGFR) were found in tumor biopsies of who patients who relapsed after vemurafenib treatment [98].